Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood-Reference-Cited by-同舟云学术

Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood

Published:2013-10-29 Issue:6 Volume:126 Page:895-905
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Belzil Veronique V.,Bauer Peter O.,Prudencio Mercedes,Gendron Tania F.,Stetler Caroline T.,Yan Irene K.,Pregent Luc,Daughrity Lillian,Baker Matthew C.,Rademakers Rosa,Boylan Kevin,Patel Tushar C.,Dickson Dennis W.,Petrucelli Leonard

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s00401-013-1199-1/fulltext.html

Reference44 articles.

1. Al-Mahdawi S, Pinto RM, Ismail O, Varshney D, Lymperi S, Sandi C et al (2008) The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum Mol Genet 17(5):735–746

2. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77(4):639–646

3. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823–837

4. Bauer PO, Zumrova A, Matoska V, Mitsui K, Goetz P (2004) Can ataxin-2 be down-regulated by allele-specific de novo DNA methylation in SCA2 patients? Med Hypotheses 63(6):1018–1023

5. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78(2):547–581

Cited by 269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics;Frontiers in Molecular Neuroscience;2024-09-13

2. Epigenetics in the formation of pathological aggregates in amyotrophic lateral sclerosis;Frontiers in Molecular Neuroscience;2024-09-03

3. Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs;Molecular Therapy - Nucleic Acids;2024-09

4. The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis;Heliyon;2024-08

5. C9orf72 polyPR interaction with the nuclear pore complex;Biophysical Journal;2024-08